New imaging platform speeds up antiviral testing with real-time plaque dynamics

Researchers have developed a novel label-free imaging platform that significantly speeds up antiviral susceptibility testing. This system uses an ultra-large-area sensor and deep learning to continuously monitor viral plaque formation, providing time-resolved data on drug efficacy. In tests with HSV-1 and acyclovir, the platform accurately matched traditional methods but delivered results approximately 26 hours faster, revealing new insights into dose-dependent viral inhibition kinetics. AI

Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →

IMPACT This new method could accelerate drug discovery and clinical diagnostics by providing faster and more detailed results for antiviral testing.

RANK_REASON The cluster contains an arXiv preprint detailing a new scientific methodology and experimental results. [lever_c_demoted from research: ic=1 ai=0.4]

Read on arXiv cs.CV →

• arXiv
• HSV-1
• acyclovir

• paper
• other